These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11406721)

  • 41. [Positron emission tomography in oncology].
    Hatazawa J; Higuchi I; Nakamura H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET and SPECT: opportunities and challenges for psychiatry.
    Reba RC
    J Clin Psychiatry; 1993 Nov; 54 Suppl():26-32. PubMed ID: 8270595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Principles and clinical applications of positron emission tomography.
    Gardner SF; Green JA; Bednarczyk EM; Farnett L; Miraldi F
    Am J Hosp Pharm; 1992 Jun; 49(6):1499-506. PubMed ID: 1530002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positron emission tomography: the conceptual idea using a multidisciplinary approach.
    Paans AM; van Waarde A; Elsinga PH; Willemsen AT; Vaalburg W
    Methods; 2002 Jul; 27(3):195-207. PubMed ID: 12183107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo tumor imaging in mice using a state-of-the-art clinical PET/CT in comparison with a small animal PET and a small animal CT.
    Seemann MD; Beck R; Ziegler S
    Technol Cancer Res Treat; 2006 Oct; 5(5):537-42. PubMed ID: 16981797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development.
    Burns HD; Hamill TG; Eng WS; Francis B; Fioravanti C; Gibson RE
    Curr Opin Chem Biol; 1999 Aug; 3(4):388-94. PubMed ID: 10419855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-resolution PET imaging and quantitation of pharmaceutical biodistributions in a small animal using avalanche photodiode detectors.
    Marriott CJ; Cadorette JE; Lecomte R; Scasnar V; Rousseau J; van Lier JE
    J Nucl Med; 1994 Aug; 35(8):1390-6. PubMed ID: 8046499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].
    vom Dahl J
    Herz; 1997 Feb; 22(1):1-15. PubMed ID: 9173038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
    Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
    J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual-modality PET/CT tomography for clinical oncology.
    Beyer T; Townsend DW; Blodgett TM
    Q J Nucl Med; 2002 Mar; 46(1):24-34. PubMed ID: 12072843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric nuclear medicine imaging.
    Biassoni L; Easty M
    Br Med Bull; 2017 Sep; 123(1):127-148. PubMed ID: 28910997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research.
    Paulus MJ; Gleason SS; Easterly ME; Foltz CJ
    Lab Anim (NY); 2001 Mar; 30(3):36-45. PubMed ID: 11385756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
    Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
    J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging tumour-bearing animals using clinical scanners.
    Wolf G; Abolmaali N
    Int J Radiat Biol; 2009 Sep; 85(9):752-62. PubMed ID: 19479601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-Dimensional Imaging of Surface Chemical Processes in Catalysis Using High-Resolution Positron Emission Tomography.
    Sarkadi-Pribóczki E; Valastyan I; Molnar J
    Chempluschem; 2013 Aug; 78(8):830-836. PubMed ID: 31986683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.
    Assmus F; Seelig A; Gobbi L; Borroni E; Glaentzlin P; Fischer H
    Eur J Pharm Sci; 2015 Nov; 79():27-35. PubMed ID: 26341407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography. Biomedical research and clinical application.
    Wolf AP; Fowler JS
    Neuroimaging Clin N Am; 1995 Feb; 5(1):87-101. PubMed ID: 7743087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.